CARDIOGENIC SHOCK
Clinical trials for CARDIOGENIC SHOCK explained in plain language.
Never miss a new study
Get alerted when new CARDIOGENIC SHOCK trials appear
Sign up with your email to follow new studies for CARDIOGENIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart pump could save lives after surgery shock
Disease control Not yet recruitingThis study tests a new device called SynFlow Duro, a temporary heart pump for people who go into severe shock after heart surgery. About 60 adults in China will receive the pump to see if it helps their heart recover or keeps them stable until a transplant or permanent device. Th…
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: ForQaly Medical (Shanghai) Co., Ltd • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New drug aims to treat deadly heart shock
Disease control Not yet recruitingThis study tests if the drug istaroxime can help people with mild to moderate cardiogenic shock caused by acute heart failure. About 600 adults will receive either istaroxime or a placebo through an IV for 48 hours. Researchers will check if it improves blood pressure, breathing,…
Matched conditions: CARDIOGENIC SHOCK
Phase: PHASE2, PHASE3 • Sponsor: Seismic Pharmaceuticals Operations LLC • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Designer cells aim to calm immune system after massive heart attack
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people in shock after a severe heart attack. The therapy uses specially engineered immune cells (CAR-DC) to target a protein found in heart scar tissue, aiming to calm the immune response. The study will enroll 18 patients and prim…
Matched conditions: CARDIOGENIC SHOCK
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Which drug saves more lives in heart shock? major trial launches
Disease control Not yet recruitingThis study compares two drugs, norepinephrine and dopamine, to see which works better as the first treatment for adults with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood. About 512 participants will be randomly assigned to receive one of …
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jun 17, 2026 12:04 UTC
-
New combo therapy aims to rescue failing hearts without transplant
Disease control Not yet recruitingThis study tests whether using a heart pump (Impella 5.5) along with standard heart failure medications can help people with severe heart failure and shock recover without needing a heart transplant or permanent artificial heart. About 250 adults with weak hearts (ejection fracti…
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Heart pump study aims to save limbs: routine catheter placement tested
Disease control Not yet recruitingThis study tests whether routinely placing a small tube (catheter) in the leg can prevent serious limb complications in patients on a heart-pump machine. About 500 adults with severe heart failure or shock will be randomly assigned to get the tube placed right away or only if nee…
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Could a common steroid speed heart shock recovery?
Symptom relief Not yet recruitingThis study tests if giving a short course of steroids (methylprednisolone) for 7 days can help adults with heart failure who are in cardiogenic shock, a serious condition where the heart can't pump enough blood. The goal is to reduce harmful inflammation and help patients recover…
Matched conditions: CARDIOGENIC SHOCK
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 09, 2026 12:10 UTC
-
Caribbean ECMO registry launches to track Life-Saving machine outcomes
Knowledge-focused Not yet recruitingThis study will collect information from 1,200 patients in the French West Indies and Guiana who received ECMO, a machine that helps the heart and lungs. Researchers aim to track survival rates and complications to better understand how ECMO works in this region. The study does n…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: University of Genova • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:00 UTC
-
Brain oxygen tracking may improve ECMO care
Knowledge-focused Not yet recruitingThis study looks at 30 adults on a heart-lung machine (ECMO) for severe heart failure. Researchers will measure brain oxygen levels and compare them to blood flow and other vital signs. The goal is to see if brain oxygen readings can help guide treatment and predict recovery.
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:56 UTC
-
New bedside test may predict death risk in ICU patients
Knowledge-focused Not yet recruitingThis study tests a new device that can measure a substance called nucleosomes in the blood right at the patient's bedside. Researchers want to see if these levels can help predict which critically ill patients are at higher risk of dying within 30 days. The study will include 130…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Erasme University Hospital • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:50 UTC
-
New device could shed light on oxygen levels in critically ill heart patients
Knowledge-focused Not yet recruitingThis study tests a new, non-invasive device called ODIN that measures how well oxygen is being used in the tiny blood vessels of patients with advanced heart failure or cardiogenic shock in the ICU. About 30 adults will have their oxygen measurements taken with the device and com…
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Hong kong launches study to track heart shock survival
Knowledge-focused Not yet recruitingThis study will track 320 people in Hong Kong who have a heart attack complicated by cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. Researchers will collect data on standard treatments, including the use of a heart pump called Impella, to…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC
-
Could a simple sedation plan transform recovery for ECMO patients?
Knowledge-focused Not yet recruitingThis study looks at whether a new, carefully designed plan for giving painkillers and sedatives to patients on ECMO (a life-support machine) is possible to use in hospitals. ECMO patients often face long-term problems like anxiety and memory issues, which may be linked to how muc…
Matched conditions: CARDIOGENIC SHOCK
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Heart Patients' breathing settings under review: could an algorithm do better?
Knowledge-focused Not yet recruitingThis study looks at 100 adults who needed a breathing machine after a heart attack or cardiac arrest. Researchers want to see how often acid-base problems happen and compare the settings doctors used with those suggested by a computer algorithm. The goal is to improve future care…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Laval University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
Heart surgery monitoring under the microscope: is the standard test reliable?
Knowledge-focused Not yet recruitingThis study looks at whether a standard way to measure pressure in the heart's left chamber (using a balloon-tipped catheter) gives the same results as the most accurate method (directly measuring pressure in the left atrium). The researchers will study 136 adults having heart sur…
Matched conditions: CARDIOGENIC SHOCK
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:18 UTC